Author:
Hughes Arlene R,Mosteller Michael,Bansal Aruna T,Davies Kirstie,Haneline Stephen A,Lai Eric H,Nangle Keith,Scott Trevor,Spreen William R,Warren Liling L,Roses Allen D,on behalf of the CNA30027 and CNA30
Subject
Pharmacology,Genetics,Molecular Medicine
Reference13 articles.
1. Cutrell A, Hernandez JE, Edwards M etal: Clinical risk factors for hypersensitivity reactions to abacavir: retrospective analysis of over 8,000 subjects receiving abacavir in 34 clinical trials. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA (2003) (Abstract H-2013).
2. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
3. Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
4. Pirmohamed M: P450 polymorphisms and adverse drug reactions. British Toxicology Society Meeting, Manchester, UK (2002) (Abstract).
5. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir
Cited by
224 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献